首页> 外文期刊>International journal of proteomics >Method for Recovery and Immunoaffinity Enrichment of Membrane Proteins Illustrated with Metastatic Ovarian Cancer Tissues
【24h】

Method for Recovery and Immunoaffinity Enrichment of Membrane Proteins Illustrated with Metastatic Ovarian Cancer Tissues

机译:转移性卵巢癌组织图示的膜蛋白的恢复和免疫亲和富集的方法

获取原文
           

摘要

Integral membrane proteins play key biological roles in cell signaling, transport, and pathogen invasion. However, quantitative clinical assays for this critical class of proteins remain elusive and are generally limited to serum-soluble extracellular fragments. Furthermore, classic proteomic approaches to membrane protein analysis typically involve proteolytic digestion of the soluble pieces, resulting in separation of intra- and extracellular segments and significant informational loss. In this paper, we describe the development of a new method for the quantitative extraction of intact integral membrane proteins (including GPCRs) from solid metastatic ovarian tumors using pressure cycling technology in combination with a new (ProteoSolve-TD) buffer system. This new extraction buffer is compatible with immunoaffinity methods (e.g., ELISA and immunoaffinity chromatography), as well as conventional proteomic techniques (e.g., 2D gels, western blots). We demonstrate near quantitative recovery of membrane proteins EDG2, EDG4, FASLG, KDR, and LAMP-3 by western blots. We have also adapted commercial ELISAs for serum-soluble membrane protein fragments (e.g., sVEGFR2) to measure the tissue titers of their transmembrane progenitors. Finally, we demonstrate the compatibility of the new buffers with immunoaffinity enrichment/mass spectrometric characterization of tissue proteins.
机译:整合膜蛋白在细胞信号传导,转运和病原体入侵中起着关键的生物学作用。但是,对于这一关键蛋白类别的定量临床测定仍然难以捉摸,通常仅限于血清可溶性细胞外片段。此外,用于膜蛋白分析的经典蛋白质组学方法通常涉及可溶性片段的蛋白水解消化,从而导致细胞内和细胞外片段的分离和大量信息丢失。在本文中,我们描述了使用压力循环技术结合新的(ProteoSolve-TD)缓冲系统从固态转移性卵巢肿瘤中定量提取完整整合膜蛋白(包括GPCR)的新方法的开发。这种新的提取缓冲液可与免疫亲和方法(例如ELISA和免疫亲和色谱法)以及常规蛋白质组学技术(例如2D凝胶,蛋白质印迹)兼容。我们通过蛋白质印迹证实了膜蛋白EDG2,EDG4,FASLG,KDR和LAMP-3的定量回收。我们还对血清可溶性膜蛋白片段(例如sVEGFR2)的商业ELISA进行了调整,以测量其跨膜祖细胞的组织滴度。最后,我们证明了新缓冲液与组织蛋白的免疫亲和富集/质谱法表征的相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号